Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
27.37
-0.40 (-1.44%)
At close: Jul 21, 2025, 4:00 PM
27.48
+0.11 (0.40%)
Pre-market: Jul 22, 2025, 8:59 AM EDT

Company Description

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.

The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals.

It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories.

The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services.

Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision.

The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers.

It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products.

The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand.

Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Baxter International Inc.
Baxter International logo
CountryUnited States
Founded1931
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees60,000
CEODavid Shafer

Contact Details

Address:
One Baxter Parkway
Deerfield, Illinois 60015
United States
Phone224 948 2000
Websitebaxter.com

Stock Details

Ticker SymbolBAX
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000010456
CUSIP Number071813109
ISIN NumberUS0718131099
Employer ID36-0781620
SIC Code3841

Key Executives

NamePosition
David Brent ShaferChair and Interim Chief Executive Officer
Joel T. GradeExecutive Vice President and Chief Financial Officer
Heather KnightExecutive Vice President and Chief Operating Officer
Jose E. AlmeidaAdvisor
Alok Sonig B.E., MbaExecutive Vice President and Group President of Pharmaceuticals
Anita A. ZielinskiSenior Vice President, Chief Accounting Officer and Controller
Tobi Karchmer M.D., M.S.Senior Vice President and Chief Medical and Scientific Officer
Charles Rusty PatelSenior Vice President and Chief Information Officer
Clare TrachtmanVice President of Investor Relations
David S. RosenbloomExecutive Vice President and General Counsel

Latest SEC Filings

DateTypeTitle
Jul 15, 2025SCHEDULE 13G/AFiling
Jul 7, 20258-KCurrent Report
Jun 12, 20258-KCurrent Report
May 30, 202525-NSEFiling
May 29, 2025SDForm - SD
May 8, 20258-KCurrent Report
May 6, 202510-QQuarterly Report
May 1, 20258-KCurrent Report
Apr 24, 2025SCHEDULE 13G/AFiling
Apr 15, 2025SCHEDULE 13GFiling